Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2000
10/05/2000WO2000058438A2 Conformationally constrained peptides
10/05/2000WO2000058365A1 Specific binding proteins for treating canine allergy
10/05/2000WO2000058362A1 Neutrokine-alpha binding proteins and methods based thereon
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058360A2 Analogs of gastric inhibitory peptide and their use for treatment of diabetes
10/05/2000WO2000058359A1 Retro-inverso prosaposin-derived peptides and use thereof
10/05/2000WO2000058358A1 49 human secreted proteins
10/05/2000WO2000058357A1 50 human secreted proteins
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058354A1 Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
10/05/2000WO2000058353A1 Npcahh01: human transmembrane protein e3-16 gene
10/05/2000WO2000058352A2 Barley gene for thioredoxin and nadp-thioredoxin reductase
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058348A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
10/05/2000WO2000058345A1 NOVEL tRNA SYNTHETASE ENZYME, COMPOSITIONS CAPABLE OF BINDING TO SAID ENZYME, AND METHODS OF USE THEREOF
10/05/2000WO2000058342A1 Process for partitioning of proteins
10/05/2000WO2000058341A1 Hookworm platelet inhibitor
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058336A1 50 human secreted proteins
10/05/2000WO2000058335A1 47 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057915A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000WO2000057912A1 Novel porcine protein and uses thereof
10/05/2000WO2000057910A1 Attenuated dengue-4 virus vaccine
10/05/2000WO2000057905A1 Recombinant neospora antigens and their uses
10/05/2000WO2000057903A2 48 human secreted proteins
10/05/2000WO2000057899A1 Thrombospondin-2 and uses thereof
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057895A1 Method for pr-39 peptide regulated stimulation of angiogenesis
10/05/2000WO2000057695A1 Autoimmune disease model animal
10/05/2000WO2000057683A2 Differentially expressed gene and protein
10/05/2000WO2000031269A3 Plant cell proliferation-associated proteins
10/05/2000WO2000031258A3 Human orphan g protein-coupled receptors
10/05/2000WO2000031142A3 Plant syr2 homologs
10/05/2000WO2000031133A3 Potassium channel interactors and uses therefor
10/05/2000WO2000031127A3 Protein fragments for use in protein targeting
10/05/2000WO2000029574A3 Inflammation-associated genes
10/05/2000WO2000029573A3 Adenoviral vectors
10/05/2000WO2000029433A3 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
10/05/2000WO2000029427A3 Antennapedia homeodomain helix 3 derived translocation vectors
10/05/2000WO2000028060A3 Cells for the production of helper dependent adenoviral vectors
10/05/2000WO2000028056A3 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS)
10/05/2000WO2000028054A3 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000027880A3 Rantes-derived peptides with anti-hiv activity
10/05/2000WO2000026634A3 Compositions and methods for screening agents that inhibit mapk mediated anti-apoptotic signals
10/05/2000WO2000026379A3 Polypeptide mediating cell permeability
10/05/2000WO2000026246A3 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000025811A3 Multicomponent meningococcal vaccine
10/05/2000WO2000025804A3 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
10/05/2000WO2000022130A3 Metastatic breast and colon cancer regulated genes
10/05/2000WO2000022122A3 Genes, proteins and biallelic markers related to central nervous system disease
10/05/2000WO2000020638A9 Methods and compositions for the diagnosis and therapy of prostate cancer
10/05/2000WO2000012736A3 A new method of identifying non-host plant disease resistance genes
10/05/2000WO2000012705A3 Methods for improving the function of heterologous g protein-coupled receptors
10/05/2000WO2000011942A9 IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE
10/05/2000WO2000011179A9 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
10/05/2000WO2000011167A3 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO1999032135A8 Keratinocyte growth factor-2 formulations
10/05/2000DE19920004C1 New cellular regulation factor TTO 20, useful for identifying specific modulators and producing antibodies for diagnosis of rheumatoid arthritis
10/05/2000DE19915178A1 Hepatitis C Virus Zellkultursystem Hepatitis C virus cell culture system
10/05/2000DE19914817A1 New DNA for the multiple peptide resistance factor of Staphylococcus, useful for identifying agents that increase bacterial sensitivity to antimicrobial peptides
10/05/2000DE19911971A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination
10/05/2000DE19909373A1 Neue PNA-Monomere, daraus resultierende PNA-Oligomere und deren Verwendung New PNA monomers, resulting PNA oligomers and their use
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368998A1 Delivery of functional protein sequences by translocating polypeptides
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368909A1 48 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368854A1 Barley gene for thioredoxin and nadp-thioredoxin reductase
10/05/2000CA2368760A1 Flint polypeptide analogs
10/05/2000CA2368744A1 Value-added traits in grain and seed transformed with thioredoxin
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368673A1 Attenuated dengue-4 virus vaccine
10/05/2000CA2368657A1 Thrombospondin-2 and uses thereof
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368638A1 Method for pr-39 peptide regulated stimulation of angiogenesis
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368482A1 50 human secreted proteins
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368376A1 50 human secreted proteins
10/05/2000CA2368374A1 47 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368234A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000CA2368233A1 Recombinant neospora antigens and their uses
10/05/2000CA2368216A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3
10/05/2000CA2368040A1 Ku80 homolog and uses thereof